Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4966 AL 4980

Metabolic Parkinson's disease

Invernizzi F, Ciocca L, Contaldi E, Inverso D, Calandrella D, Mignone F, Barichella M, Isaias IU, Pezzoli G.

Front Aging Neurosci. 2025 Oct 10;17:1665957. doi: 10.3389/fnagi.2025.1665957. eCollection 2025.

Parkinson's disease beyond the brain: implications for treatments

Malekian Naeini S, Lopez MD, Fraser PE, Tandon A.

Front Aging Neurosci. 2025 Oct 9;17:1600782. doi: 10.3389/fnagi.2025.1600782. eCollection 2025.

Real-world evidence of pimavanserin utilization among patients with Parkinson's disease psychosis: a review of real-world data that augments data from randomized controlled trials

Rashid N, Yunusa I, Doshi D, Yakkala V, Gopal D, Abler V, Rajagopalan K.

J Comp Eff Res. 2025 Dec;14(12):e250129. doi: 10.57264/cer-2025-0129. Epub 2025 Oct 27.

Further Investigation of Catechol-O-Methyltransferase Gene and Parkinson's Disease Susceptibility in the UK Biobank Cohort

Hu Z, Wan JJ, Yan QQ, Fan Y, Liu J.

Mov Disord. 2025 Dec;40(12):2858-2860. doi: 10.1002/mds.70098. Epub 2025 Oct 27.

Effects of resistance and balance training on motor and non-motor symptoms in patients with Parkinson's disease: a meta-analysis

Wang Z, Zhu C, Miao W, Zhang Y.

Neurol Res. 2025 Oct 27:1-14. doi: 10.1080/01616412.2025.2578352. Online ahead of print.

Adherence to Animal Research: Reporting of In Vivo Experiments Guidelines in Stem Cell Studies in Animal Models of Parkinson's Disease: A Systematic Review

Park JM, Sung BK, Myung JY, Lee SC, Yon DK, Shin JI, Kim YW, Ioannidis JPA.

Yonsei Med J. 2025 Nov;66(11):743-752. doi: 10.3349/ymj.2024.0409.

Non-invasive versus invasive techniques for predicting idiopathic normal-pressure hydrocephalus in shunt-responsive patients

Wouters K, St Brice K, Olvera-Castro JF, Ayoub DB, Salian NM, von Quednow E, Abbas MS, da Silveira Maia M, Secco GL, de Moraes Mangas G, de Amorim SO, Bozkurt I, Chaurasia B, Bertani R, Pinto FCG.

Neurosurg Rev. 2025 Oct 28;48(1):741. doi: 10.1007/s10143-025-03895-2.

A Variant of OTUD3 in Early-Onset Parkinsonism

Ahmad SR, Nasir N, Kumari A, Hassan AU.

Neuropathol Appl Neurobiol. 2025 Oct;51(5):e70046. doi: 10.1111/nan.70046.

Staging and markers in Parkinson's disease and Lewy body disorders: narrative review

Bougea A.

Ther Adv Chronic Dis. 2025 Oct 22;16:20406223251381099. doi: 10.1177/20406223251381099. eCollection 2025.

Treatment Options for Motor Fluctuations in Parkinson's Disease

Höglinger G, Lingor P, Höllerhage M, Trenkwalder C.

Mov Disord. 2025 Dec;40(12):2848-2849. doi: 10.1002/mds.70107. Epub 2025 Oct 28.

Reply: "Treatment Options for Motor Fluctuations in Parkinson's Disease"

de Bie RMA, Katzenschlager R, Bruno V, Sampaio C, Fox SH, Silverdale MA.

Mov Disord. 2025 Dec;40(12):2850-2851. doi: 10.1002/mds.70109. Epub 2025 Oct 28.

LRRK2 and the fragile synapse: a molecular prelude to Parkinson's disease?

Masotti B, Tombesi G, Parisiadou L, Greggio E.

Biochem J. 2025 Oct 28;482(21):1585-605. doi: 10.1042/BCJ20253351.

Artificial intelligence in gut microbiome research: Toward predictive diagnostics for neurodegenerative disorders

Kumar R, Nagraik R, Lakhanpal S, Abomughaid MM, Jha NK, Gupta R.

Acta Microbiol Immunol Hung. 2025 Oct 28;72(4):296-312. doi: 10.1556/030.2025.02725. Print 2025 Nov 27.

Role of NLRP3 Inflammasomes in Disorders of Children's Digestive Systems: A Narrative Review

ELMeneza S.

Pediatr Rep. 2025 Oct 7;17(5):103. doi: 10.3390/pediatric17050103.

Personalized Medicine for Chronic Diseases Through the Integration of Health Determinants Control in Patients: A Systematic Review

Bremond M, Raigneau MC, Burnel J, Pautrat M.

J Pers Med. 2025 Sep 30;15(10):462. doi: 10.3390/jpm15100462.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias